Kirn et al. observed methylation of the promoter of the estrogen receptor 1 (ESR1) gene in 19 out of 25 primary breast cancer cases, but this fraction increased to 24/25 in metastatic disease [94]. The gene discussed is ESR1; the disease is breast cancer.